| AKI | Acute kidney injury |
| ARE | Antioxidant response element |
| ARRIVE | Animal Research: Reporting of In Vivo Experiments guidelines |
| BUN | Blood urea nitrogen |
| CAT | Catalase |
| CI | Confidence interval |
| CP | Cyclophosphamide |
| DNA | Deoxyribonucleic acid |
| ERK | Extracellular signal-regulated kinase |
| GSH | Reduced glutathione |
| GSSG | Oxidised glutathione |
| HO-1 | Heme oxygenase-1 |
| IL | Interleukin |
| i.p. | Intraperitoneal |
| KIM-1 | Kidney injury molecule-1 |
| MAPK | Mitogen-activated protein kinase |
| MD | Mean difference |
| MDA | Malondialdehyde |
| MPO | Myeloperoxidase |
| NF-κB | Nuclear factor kappa B |
| NGAL | Neutrophil gelatinase-associated lipocalin |
| NLRP3 | NLR family pyrin domain-containing 3 inflammasome |
| Nrf2 | Nuclear factor erythroid 2-related factor 2 |
| OSI | Oxidative stress index |
| PPAR-γ | Peroxisome proliferator-activated receptor gamma |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| RoB | Risk of bias |
| SD | Standard deviation |
| SEM | Standard error of the mean |
| SMD | Standardised mean difference |
| SOD | Superoxide dismutase |
| SYRCLE | Systematic Review Centre for Laboratory Animal Experimentation |
| TBARS | Thiobarbituric acid reactive substances |
| TAC | Total antioxidant capacity |
| TGF-β | Transforming growth factor beta |
| TNF-α | Tumour necrosis factor alpha |
| TOS | Total oxidant status |
| TUNEL | Terminal deoxynucleotidyl transferase dUTP nick end labelling |
| Wnt | Wingless/Integrated signalling pathway |